Cited by 37Mobile Health and mHealth ApplicationsDigital Mental Health InterventionsObesity, Physical Activity, Diet

Comparing Digital Therapeutic Intervention with an Intensive Obesity Management Program: Randomized Controlled Trial

Open access
Moravcová, Katarína, Karbanová, Martina, Bretschneider, Maxi Pia, Sovová, Markéta, Ožana, Jaromír, Sovová, Eliška·2022·Nutrients

Abstract

In this study, we evaluated whether the digital program Vitadio achieves comparable results to those of an intensive in-person lifestyle intervention in obesity management. This is a 12-month prospective, randomized controlled trial. Obese patients with insulin resistance, prediabetes or type 2 diabetes were included. The intervention group (IG) used Vitadio. The control group (CG) received a series of in-person consultations. Body weight and various metabolic parameters were observed and analyzed with ANOVA. The trial is ongoing and the presented findings are preliminary. Among 100 participants (29% men; mean age, 43 years; mean BMI, 40.1 kg/m2), 78 completed 3-month follow-up, and 51 have completed the 6-month follow-up so far. Participants significantly (p < 0.01) reduced body weight at 3 months (IG: −5.9 ± 5.0%; CG: −4.2 ± 5.0%) and 6 months (IG: −6.6±6.1%; CG: −7.1 ± 7.1%), and the difference between groups was not significant. The IG achieved favorable change in body composition; significant improvement in TAG (−0.6 ± 0.9 mmol/l, p < 0.01), HDL (0.1 ± 0.1%, p < 0.05), HbA1c (−0.2 ± 0.5%, p < 0.05) and FG (−0.5 ± 1.5 mmol/l, p < 0.05); and a superior (p = 0.02) HOMA-IR reduction (−2.5 ± 5.2, p < 0.01). The digital intervention achieved comparable results to those of the intensive obesity management program. The results suggest that Vitadio is an effective tool for supporting patients in obesity management and diabetes prevention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu14102005

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vitadio complements physician-directed therapy and helps patients achieve their treatment goals.

    “Built on a multimodal therapeutic approach, Vitadio complements physician-directed therapy and helps patients in achieving their treatment goals [24,25].”

    From Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial (2025) · cites this paper as [24]

    The Introduction describes Vitadio as a multimodal program that supports self-management and personalized goal setting, and the Conclusions report improvements in weight and metabolic measures. But Materials and Methods §2.4 says the Vitadio group received the app without in-person lifestyle consultation; the study compared it with clinician-provided consultations rather than showing that it complements physician-directed therapy. Page numbers are not available in our copy. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • In a study of digital intervention in patients with obesity, the intervention group exhibited significant improvements in HbA1c, fasting blood glucose, and HOMA-IR levels while retaining muscle mass and reducing body fat and obtained equivalent outcomes to an intensive obesity management program.

    “In a study of digital intervention in patients with obesity, the intervention group exhibited significant improvements in HbA1c, fasting blood glucose, and HOMA-IR levels while retaining muscle mass and reducing body fat and obtained equivalent outcomes to an intensive obesity management program [37].”

    From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [37]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moravcová, K., Karbanová, M., Bretschneider, M. P., Sovová, M., Ožana, J., & Sovová, E.
Affiliations
  • University Hospital Olomouc (CZ)
  • Charles University (CZ)
  • Technische Universität Dresden (DE)
Corresponding author
Moravcová, Katarína
Venue
Nutrients
Publisher
MDPI AG
Published
2022-05-10
Volume
14
Issue
10
Pages
2005
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4280607715
Cited by
37
References
37
Citations by year
2026: 8 · 2025: 5 · 2024: 9 · 2023: 8 · 2022: 7
FWCI
8.31
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Palacký University Olomouc (IGA_LF_2020_030)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
digital therapeutics, obesity treatment, lifestyle intervention, type 2 diabetes prevention, prediabetes, insulin resistance, weight loss, body composition, HOMA-IR, HbA1c, HDL cholesterol, triglycerides, fasting blood glucose
MeSH terms
Obesity Management, Adult, Body Weight, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Obesity, Prospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review